Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.

Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

From an eccentric idea to a revolution in medicine – the history of immunotherapy and a peek into its future.

One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.

John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.

Novartis works with visual artist Noma Bar and international patient group MDS Alliance to send a message of hope to people living with myelodysplastic syndromes.

Eyesight initiatives are restoring vision – and hope – to thousands of people in Southeast Asia by expanding equitable access to eye care.

More than 100,000 patients with heart failure in China are using our new AI-enabled platform, AI Nurse, to manage their condition and aim for better health.

To showcase how people living with ITP triumph and persevere, Novartis partnered with photographer Kate T. Parker on a series of photo essays.

Novartis researchers aim to improve the lives of patients with osteoarthritis.

Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.